Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Medications for Opioid Use Disorder

June 2, 2022
8:00 am–9:00 am ET

This training will provide an overview of the 3 FDA-approved medications for the treatment of opioid use disorder (OUD): buprenorphine, methadone, and naltrexone.

Register now

Virtual meeting

Via Zoom


Boston Medical Center's Grayken Center for Addiction TTA is pleased to announce a comprehensive new training series aimed at advancing addiction treatment among health care professionals. This recurring series consists of 16 hours of training covering 20 topics. You can attend all sessions or select specific ones. 
Foundational topics in this series include an introduction to substance use disorders (SUDs) and stigma, screening for SUDs, motivational interviewing, harm reduction, and medications for opioid use disorder (MOUD). Clinically-focused sessions will review alcohol, benzodiazepine, and stimulant use disorders, in addition to MOUD implementation strategies, co-occurring disorders, and medical considerations for persons using substances. Population-specific trainings will discuss SUD as it relates to adolescents and young adults, older adults, peripartum persons, and those with a brain injury. Specialty topics include cannabis, criminal-legal involvement, overdose education and naloxone distribution, pain management, lab testing/toxicology screening, and regulatory issues relating to MOUD. 
These trainings, formerly used for advanced practice providers (APPs) applying for their DEA X-waiver, will continue to count towards the additional 16 hrs required for APPs. 

Intended audience

Physcians, Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), Physician Assistants, Nurses, Licensed Practical Nurses (LPN)


Andrea Jodat, DNP, FNP-BC, CARN-AP Nancy Regan, NP, CNM


Following completion of this training, participants will have the knowledge necessary to:

Sponsored by

Bureau of Substance Addiction Services (DPH/BSAS), Providers Clinical Support System (PCSS), and Boston Medical Center Grayken Center for Addiction TTA

American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this waiver training.

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information, visit

Accreditation information

CEUs are pending approval.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2022 Boston Medical Center. All rights reserved. Site by Signal.